Please note that we charge an extra fee for prenatal analysis.
Prenatal Testing Is Given the Highest Priority at CENTOGENE
Learn more about our prenatal genetic testing options, which enable rapid and reliable identification of disease-causing mutations, even at the early stages of pregnancy.
Prenatal Testing and Diagnosis
Chooising the appropriate testing strategy is crucial in providing the best care for your patients.
This is why CENTOGENE offers a turnaround time of ten business days for most prenatal analyses (known variants, deletion/duplication analysis, single gene sequencing) and of less than 15 business days for Next Generation Sequencing (NGS) analyses (CentoXome®, CentoGenome® and CentoArray®). In addition, our medical experts are always available for your support before, during, and after the analysis.
Starting Material
- Chorionic villi
- Amniotic fluid
- Fetal DNA
- Cord blood (for late pregnancies) as possible material
You have the option to send us tubes with already cultivated cells. Alternatively, we offer CentoCulture®, our cell cultivation service.
Contact Us
Please always contact us prior to every prenatal sample sending to prevent transport delays and to allow us to give the analysis top priority. Please provide the following mandatory information :
- Logistics tracking number of sample shipment
- Requested analysis
- Physician's contact information
All prenatal cases are specifically assigned to our dedicated prenatal team who takes the utmost individual care.
Contact Details
Logistic and Communication Manager
+49 381 80113 663
logistics@centogene.com
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.
Resources
Downloads
Gene List Prenatal Testing
CENTOGENE’s prenatal gene list for CentoXome® and CentoGenome® analysis
Scientific Publications
Mendelian Disease Gene Identification and Diagnostics Using Targeted Next Generation Sequencing
During the last few months we have observed for the first time since the introduction of the first massive parallel sequencers in 2007, that the cost of sequencing a human genome has not changed […]
Loading...
Validation of a Semiconductor Next-Generation Sequencing Assay for the Clinical Genetic Screening of CFTR
Genetic testing for cystic fibrosis and CFTR-related disorders mostly relies on laborious molecular tools that use Sanger sequencing to scan for mutations in the CFTR gene. We have explored a more […]
Loading...
Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Diagnostics of Breast and/or Ovarian Cancer
We explored a more efficient genetic screening strategy based on next-generation sequencing of the BRCA1 and BRCA2 genes in 210 hereditary breast and/or ovarian cancer patients.
Loading...
Related Webinars
Complete Oncogenetic Workflow
Looking for a one-stop-solution for your laboratory? Join this webinar to learn more about our CentoCloud® for diagnostic NGS panels, clinical bioinformatics & medical interpretation in the […]
Loading...
A Journey to the Future – Whole Genome Sequencing for the Diagnosis of Heterogeneous Genetic Disorders
Last year CENTOGENE announced its new sequencing facility for rare hereditary disorders, which uses Illumina’s HiSeq X® sequencer. Some months after our journey started, our CSO Prof. Peter Bauer […]
Loading...
Get in Touch With Our Customer Support
Our consultation service is available in several languages.
+49 (0) 381 80 113 - 416
Mon. – Fri. 7 a.m. – 6:30 p.m. CET
Sat. 8 a.m. – 12 p.m. CET
PLEASE NOTE
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.